The Zoe COVID Study’s positive symptomatic case estimate is currently 122,519 cases (-25.4% in a week). The 7-day estimate shows 971,768 cases in a week (-25.9%). On average, it is now estimated that at least 138,824 people are still infected by coronavirus every day in the UK.
First published in August 2022.
- 📆 Latest Summary
- ⏰ Latest Guidance
- 📻 Latest News
- 🐦 Tweets
- 📌 Must-Read
- 🧬 Variants News
- 🧩 Long COVID
- 📄 Additional Data
- 📚 Data Sources
Latest UK Dashboard
Since 27 July we don’t publish the UKHSA data in our daily reporting. Those figures are just conveniently and undoubtedly flawed. Instead, we now focus on the ZOE COVID Study and the ONS Infection Survey data. This is why:
Our reporting strategy
Since 27 July we don’t publish the UKHSA data in our daily reporting. Those figures are just conveniently and undoubtedly flawed. Instead, we now focus on the ZOE COVID Study and the ONS Infection Survey data.
Our readers deserve the truth about COVID-19 and the UK government has clearly been doing everything – from ending free tests to irregular dashboard reports, delaying and ending some data reports – to make sure the media slowly lose interest in COVID reporting and get the public to believe both that they can live with the virus and that the pandemic is over. This is wrong and untrue, as the WHO and most public health experts have repeatedly told us.
For these reasons, PMP Magazine has so far, and will continue to publish COVID daily updates because we see it as part of our mission to always report the truth, even if it means we are the last media in the UK to do so.
While others are sleepwalking to hide the inconvenient truth about COVID-19, PMP Magazine isn’t giving up! Our daily report is free and accessible to all.
Please support our work with a donation: PMP-Magazine.com/crowdfunding
COVID is not over.
Reminder on data reporting in the UK
▫ Since 1 July 2022, the COVID-19 UKHSA Dashboard has moved to weekly reporting.
▫ The reporting of ZOE COVID Study data has remained daily.
▫ The reporting of ONS Infection Survey data has remained weekly with a 7-day lag.
(Source: UKHSA | ZOE | ONS)
Zoe COVID Study Estimates
■ Daily Estimated Cases
ONS Infection Survey Estimates
■ Weekly Estimates Cases
■ Weekly COVID-19 Recorded Deaths
Deaths involving COVID-19 increased in the UK
According to the ONS, there were 921 deaths involving COVID-19 registered in the UK in the week ending 29 July 2022, an increase from 864 in the previous week. This accounted for 7.3% of all deaths in the latest week, an increase from 6.9% in the previous week.
In England, the number of deaths involving COVID-19 increased from 697 in the previous week to 745 in the latest week (ending 29 July 2022).
The number of deaths involving COVID-19 in England increased in groups aged 65 years and over, decreased in groups aged 45 to 64 years and remained similar in those aged under 25 years (in the week ending 29 July 2022). Deaths involving COVID-19 increased in most English regions, except the North West, South West and London, where they decreased.
UKHSA Latest Data – ENGLAND ONLY
The data below are as officially reported today for the latest ‘available’ data set in each case, and produced by Dr Joe Pajak.
■ UK Government’s List of symptoms of COVID-19
After two years without updating its list of just three symptoms of COVID-19 (a high temperature, a new continuous cough and a loss or change to the sense of smell or taste), the NHS has finally updated its list of symptoms of COVID:
😩 Shortness of breath
🥱 Feeling tired or exhausted
🤕 An aching body
🤯 A headache
🤐 A sore throat
🤧 A blocked or runny nose
😞 Loss of appetite
🤮 Feeling sick or being sick
■ TRAVEL: ENTRY RULES AND RESTRICTIONS
Check out the latest situation for 20 of the top travel destinations for Brits:
■ ZOE COVID Study’s Top 20 symptoms of COVID-19 (as of 28-Jul-2022)
Antibody levels remained high in adults across the UK — ONS
In the UK, the proportion of adults with antibodies at or above the 179ng/ml level remains high. An estimated 96.3% of the adult population in England, 96.1% in Wales, 95.5% in Northern Ireland and 95.9% in Scotland had antibodies against SARS-CoV-2 at or above the 179ng/ml level in the most recent week (beginning 11 July 2022).
At or above the higher level of 800ng/ml, an estimated 71.9% of the adult population in England, 71.7% in Wales, 71.0% in Northern Ireland and 72.3% in Scotland had antibodies against SARS-CoV-2. Antibody levels at or above 800ng/ml vary by age group and are highest in those aged 75 years and over, corresponding to the rollout of fourth vaccinations for these age groups. These estimates at or above the 800ng/ml level are not comparable with our estimates published on 4 May 2022 because of method changes since this publication. Details of method changes can be found in the Coronavirus (COVID-19) Infection Survey: antibody bulletin.
In Great Britain, an estimated 90.9% of children aged 12 to 15 years, and 73.1% of children aged 8 to 11 years, had antibodies against SARS-CoV-2 at or above the 179ng/ml level.
Fatigue and sore throat as main symptoms
The Zoe COVID Study founder Professor Tim Spector warned on Twitter that fatigue in the morning and a sore throat might be signs of COVID infection.
“Twice as many COVID cases as common colds currently – the ratio has never been so high. Symptoms are much the same except generally more fatigue and sore throat – so best to assume it’s COVID! Hopefully, this wave will be over soon.
“Try to get tested if you can. If you can’t get tested, assume you’ve got a cold and stay away from other people until you feel better.
“New study suggests that new BA4 and BA5 variants work by both evading the existing immune defences and also neutralising some of them. No surprise they are so successful as UK cases soar to record levels.”
sign up to our FREE Briefings today.
we need your help
Since February 2022, the UKHSA has slowly reduced the publishing of its daily COVID updates, following the UK Government’s narrative that we should all “live with the virus”. UKHSA now reports only once a week.
The virus doesn’t take a break 6 days a week.
It doesn’t infect people from time to time.
It doesn’t stop at a border either.
The virus still spreads and kills people every day in the UK and around the world. COVID-19 is NOT over.
We, at PMP, have decided to continue to publish the latest COVID data available every day, especially the Zoe COVID Study estimates – probably more accurate than the UK Government’s own data since free testing has ended in England, and the ONS COVID Infection Survey estimates.
Please, support our work through our crowdfunding to help us to continue our COVID reporting: Donate now.
■ 🧬 COG-UK sequencing
🚨 1.8 million people currently live with long COVID in the UK (vs 2 million last month)
🚨 2.8% of the UK population currently live with long COVID (vs 3%)
🚨 1 in 37 people in the UK has long COVID
🚨 Long COVID symptoms still adversely affect the day-to-day activities of 1.3 million people, 72% of long COVID sufferers (vs 1.4 million)
🚨 Of those, 369,000 people (21%) are “limited a lot” (vs 409,000)
🚨 530,000 (30%) first had COVID-19 before Alpha became the main variant; 221,000 (12%) in the Alpha period, 356,000 (20%) in the Delta period, and 586,000 (33%) in the Omicron period.
🚨 Most common symptoms of long COVID
▫ fatigue (54%)
▫ shortness of breath (31%)
▫ loss of smell (23%)
▫ muscle ache (22%)
🚨 Prevalence of long COVID is greatest in people
▫ aged 35-69 years
▫ living in more deprived areas
▫ working in social care, teaching, education or health care
▫ with another activity-limiting health condition or disability
▫ 1 in 20 people are neither employed nor seeking paid work
▫ 1 in 29 people are unemployed but seeking work
🚨 Long COVID by occupation (ONS – 29 Jun-2022)
▫ Police and protective services (25%)
▫ Education (22%)
▫ Social care sector (22%)
long covid kids
🧩 Long COVID Kids
According to a recent systematic review and meta-analyses of Long-COVID in children and adolescents published in Nature:
🚨 Long COVID affects 1 in 4 infected children (25.24%)
🚨 For hospitalised children, prevalence of long-COVID is nearly 1 in 3 infected children (29.19%)
🚨 Most prevalent clinical manifestations of Long COVID in children/adolescents:
▫ mood symptoms (16.50%)
▫ fatigue (9.66%)
▫ sleep disorders (8.42%)
▫ headache (7.84%)
▫ respiratory symptoms (7.62%)
▫ sputum production or nasal congestion (7.53%)
▫ cognitive symptoms (6.27%)
▫ loss of appetite (6.07%)
▫ exercise intolerance (5.73%)
▫ altered smell (5.60%)
🚨 Children infected by COVID-19 have a higher risk of persistent dyspnea, anosmia/ageusia, and/or fever
🚨 Like adults, the pediatric population’s risk factors associated with long-COVID are:
▫ older age children
▫ female gender
▫ severe COVID-19
▫ comorbid allergic diseases and other long-term co-morbidities
The authors of the systematic review and meta-analyses of Long-COVID in children and adolescents conclude:
“Long-COVID represents a significant public health concern, and there are no guidelines to address its diagnosis and management.
“Our meta-analyses further support the importance of continuously monitoring the impact of long-COVID in children and adolescents and the need to include all variables and appropriate control cohorts in studies to better understand the real burden of pediatric long-COVID.”
■ Number of contact tracing alerts sent (England & Wales)
(Source: University of Oxford)
📚 Data Sources:
- Daily summary: Coronavirus in the UK | UK Government
- Coronavirus (COVID-19) NHS Advice | PMP Magazine
- Variants: distribution of cases data | UK Health Security Agency (UKHSA)
- Vaccination Data | UK Government
- What’s new | UK Government
— AUTHOR —
▫ J.N. PAQUET, Author & Journalist, Editor of PMP Magazine.
- Text: This piece was first published in PMP Magazine on 10 Aug 2022. | The authors write in a personal capacity.
- Data cross-referenced with the latest official data from the UK dashboard.
- Cover: Adobe Stock/SergeyBitos.
- Icons from www.flaticon.com